TirelliU., ZagonelV., VolpeR.: Non-Hodgkin's lymphoma in the elderly: a retrospective evaluation of toxicity related to aggressive vs. conservative treatments. Tumori, 74: 433–438, 1988.
2.
TirelliU., ZagonelV., SerrainoD.: Non-Hodgkin's lymphoma in 137 patients aged 70 years or older. A retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. J Clin Oncol, 6: 1708–1713, 1988.
3.
CarboneA., VolpeR., GloghiniA.: Non-Hodgkin's lymphoma in the elderly. I. Pathologic features at presentation. Cancer, 66: 1991–1994, 1990.
4.
OrlandiE., LazzarinoM., BrusamolinoE.: Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results. Haematologica, 76: 204–208, 1991.
5.
TirelliU., CarboneA., CrivellariD.: A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients. Cancer, 54: 393–396, 1984.
6.
TirelliU., CarboneA., ZagonelV.: Non-Hodgkin's Lymphomas in the Elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patients. Eur J Cancer Clin Oncol, 23: 535–540, 1987.
7.
ZagonelV., TirelliU., CarboneA.: Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma. Cancer Invest, 8: 577–582, 1990.
8.
TirelliU., ZagonelV., ErranteD.: A prospective study of a new combination of chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma. J Clin Oncol, 10: 228–236, 1992.
9.
MonfardiniS., SaccoC., SerrainoD.: Effects of G-CSF in patients with non-Hodgkin's lymphomas (NHL) older than 70 years. Ann Oncol, 7: S164, 1996.
10.
ZagonelV., MonfardiniS., TirelliU.: Management of hematologic malignancies in the elderly: 15-year experience at the Aviano Cancer Center, Italy. Crit Rev Oncol Hemat, 39: 289–305, 2001.
11.
SalvagnoL., ContuA., BiancoA.: A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma. Ann Oncol, 3: 833–837, 1992.
12.
SalvagnoL., BiancoA., AversaS.: Mitoxantrone, Vepesid, Prednisone, Bleomycin and Vincristine (MVP-BV) in elderly (> 70 yaers) patients with non-Hodgkin Lymphoma: a preliminary report from Non-Hodgkin Lymphoma Cooperative Study Group (NHLCG). Proc ASCO, 20: 1155, 2001.
13.
ZinzaniP.L., BendandiM., GherlinzoniF.: VNCOP-B regimen in the treatment of high grade non-Hodgkin's lymphoma in the elderly. Haematologica, 78: 378–82, 1993.
14.
ZinzaniP.L., PavoneE., StortiS.: Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood, 89: 3974–3979, 1997.
BellesiG., RigacciL., AlteriniR.: A new protocol (Mi-CEP) for the treatment of intermediate or high-grade non-Hodgkin's lymphoma in the elderly. Leuk Lymph, 20: 475480, 1996.
17.
MerliF., FedericoM., AvanziniP.: Weekly administration of vincristine, cyclophosphamide, mitoxantrone, bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Haematologica1998, 83: 217–
18.
ChisesiT., PolistenaP., ContuA.: Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-hodgkin's lymphoma: an effective and non toxic therapeutic alternative for adult and elderly patients. Leuk Lymph, 41: 125–136, 2001.
19.
ErranteD., SorioR., ZagonelV.: A phase II study of oral idarubicin (4-demethoxidaunorubicin)in previously untreated elderly patients with non-Hodgkin's lymphoma. Am J Clin Oncol, 14: 243–245, 1991.
20.
MorraE., GargantiniL., NosariA.: Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators. Crit Rev Oncol Hematol, 35: 95–100, 2000.
21.
RobieuxI., SpazzapanS., FratinoL.: Pharmacokinetics and safety of Idarubicin continous infusion in elderly patients with aggressive lymphomas. Proc ASCO, 17: 222, 1998.
22.
MartelliM., GuglielmiC., ColuzziS.: P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma. J Clin Oncol, 11: 2362–236, 1993.
23.
CaraccioloF., PetriniM., CapochianiE.: Third generation chemotherapy with P-VABEC for aggressive Non-Hodgkin's lymphomas of the elderly. Leuk Lymph, 11: 115–118, 1993.
24.
CaraccioloF., CapochianiE., PapineschiF.: Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the treatment of intermediate and high grade non-Hodgkin's lymphoma of the elderly. Leuk Lymph, 24: 355–361, 1997.
25.
BertiniM., FreiloneR., VitoloU.: P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma. Ann Oncol, 5: 895–900, 1994.
26.
BertiniM., FreiloneR., VitoloU.: The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen. Leuk Lymph, 22: 483–493, 1996.
27.
ZinzaniP.L., TaniM., Stefoni: Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma. Haematologica, 86: 287–290, 2001.
28.
OlivieriA., CapelliD., MontanariM.: Very low toxicity and good quality of life in 48 elderly patients autotrasplanted for hematological malignancies: a single center experience. Bone Marrow Transpl, 27: 1189–1195, 2001.
29.
ZagonelV., BabareR., MerolaM.C.: Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy. Ann Oncol, 5: S127–S132, 1994.
